Unlocking the power of transcription factors to reverse diseases
Core Bio’s REPROGRAM AI platform was built to overcome the limitations of conventional transcription-factor (TF) drug discovery by identifying the TFs that control diseased networks – in their biological context, not in isolation – and designing drugs that precisely block those TFs to reprogram the network and reverse disease.
REPROGRAM AI overview
Network library from >10M cells & 11k patients
Selects dominant targets from networks
Designs potent & selective TF motifs drugs
Reprograms networks to reverse diseases
Multi-TF decoy therapeutics
COR-hyperOligo decoys block multiple TFs with a single compound. COR-H compounds mimic the DNA motif of their target TFs and bind them before they bind the genome to regulate pathological genes.
Oral DNA binding small molecules
COR-Small molecules combine DNA motif potency, specificity and oral properties. COR-S compounds bind to specific TF motifs on the genome, preventing TF access to those specific sites to regulate pathological genes.